Jones Lang LaSalle
GlaxoSmithKline posts 45% rise in fourth-quarter profit (GSK, UK:GSK)
By Steve Goldstein
LONDON (MarketWatch) -- GlaxoSmithKline (GSK) (UK:GSK) on Wednesday said fourth-quarter earnings rose 45% to 1.12 billion pounds ($1.34 billion), or 19.6 pence a share, with revenue up 8% to 5.91 billion pounds. Its 2005 earnings of 82p a share on revenue of 21.66 billion pounds each edged ahead of Thomson First Call-compiled analyst forecasts. For 2006, GlaxoSmithKline expects earnings per share to rise around 10% at constant currencies and expects to file for approval for its Cervarix cervical cancer vaccine before the end of the year in the U.S. and in Europe in the next few weeks. Glaxo shares rose 0.8% in a falling London market.
GlaxoSmithKline posts 45% rise in fourth-quarter profit (GSK, UK:GSK)
By Steve Goldstein
LONDON (MarketWatch) -- GlaxoSmithKline (GSK) (UK:GSK) on Wednesday said fourth-quarter earnings rose 45% to 1.12 billion pounds ($1.34 billion), or 19.6 pence a share, with revenue up 8% to 5.91 billion pounds. Its 2005 earnings of 82p a share on revenue of 21.66 billion pounds each edged ahead of Thomson First Call-compiled analyst forecasts. For 2006, GlaxoSmithKline expects earnings per share to rise around 10% at constant currencies and expects to file for approval for its Cervarix cervical cancer vaccine before the end of the year in the U.S. and in Europe in the next few weeks. Glaxo shares rose 0.8% in a falling London market.
posted by Jones Lang LaSalle NJ News Blog at 10:51 AM
<< Home